INNOVATIVE THERAPIES FOR SKIN DISEASES
ALMIRALL S.A.
Object
Topic: Dermatology.
Destination: Almirall is looking for partnering opportunities on new assets (small molecules, biologics, or advanced therapies) in clinical or preclinical development stages that could be used for the treatment of dermatological conditions. The assets should involve any therapeutic modality such as small molecules, biologics, or advanced therapies:
- Targeting immuno-inflammatory pathways with rationale for dermatological indications such as atopic dermatitis, hidradenitis suppurativa, alopecia areata, and vitiligo, or
- Suitable for non-melanoma skin cancer (basal and squamous cell carcinoma, and cutaneous T cell lymphoma), or rare dermatological indications (e.g., epidermolysis bullosa, pemphigus vulgaris, bullous pemphigoid, …)
- For pre-clinical assets, compelling in vitro and in vivo evidence of efficacy will be highly valuable.
Budget: Not indicated.
Duration: Not indicated.
